clarithromycin has been researched along with Diseases, Peripheral Vascular in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ärnlöv, J; Bring, C; Carlsson, AC; Gluud, C; Hilden, J; Jakobsen, JC; Jensen, GB; Kastrup, J; Kjøller, E; Kolmos, HJ; Larsson, A; Sajadieh, A; Winkel, P; Wuopio, J | 1 |
| Berg, HF; Kluytmans, JA; Maraha, B; Peeters, MF; Quarles-van Ufford, M; Scheffer, GJ; Vandenbroucke-Grauls, CM | 1 |
2 trial(s) available for clarithromycin and Diseases, Peripheral Vascular
| Article | Year |
|---|---|
Cathepsin B and S as markers for cardiovascular risk and all-cause mortality in patients with stable coronary heart disease during 10 years: a CLARICOR trial sub-study.
Topics: Aged; Angina, Unstable; Atherosclerosis; Cardiovascular Diseases; Cathepsin B; Cathepsins; Cerebrovascular Disorders; Clarithromycin; Coronary Disease; Denmark; Female; Follow-Up Studies; Glomerular Filtration Rate; Humans; Lysosomes; Male; Middle Aged; Mortality; Myocardial Infarction; Peripheral Vascular Diseases; Proportional Hazards Models; Registries; Risk Factors; Treatment Outcome | 2018 |
Treatment with clarithromycin prior to coronary artery bypass graft surgery does not prevent subsequent cardiac events.
Topics: Aged; Angina, Unstable; Anti-Bacterial Agents; Atherosclerosis; Chlamydophila Infections; Chlamydophila pneumoniae; Clarithromycin; Coronary Artery Bypass; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Myocardial Infarction; Peripheral Vascular Diseases; Stroke; Surgical Wound Infection; Treatment Outcome | 2005 |